Lymphir: US approves therapy for rare blood cancer
The US Food and Drug Administration has approved Lymphir, Citius Pharmaceuticals' therapy, for patients with… Read More
1 year ago
The US Food and Drug Administration has approved Lymphir, Citius Pharmaceuticals' therapy, for patients with… Read More